Literature DB >> 17763385

Intrahepatic portal cavernoma as an indication for liver transplantation.

Cristina H Hajdu1, Takahiro Murakami, Thomas Diflo, Bachir Taouli, Jordan Laser, Lewis Teperman, Lydia M Petrovic.   

Abstract

Cavernous transformation of the portal vein (portal cavernoma) consists of a periportal or/and intrahepatic venous collateral network, developed as a result of acute or long-standing portal vein thrombosis. Better control of hemorrhagic and thrombotic complications in the patients with portal cavernoma substantially improves their life span and the clinical outcome. However, biliary complications that occur in the late stages of this disease have been recently recognized as challenging management issues because they recur and are difficult to treat. Because of the relatively small number of the patients with cholangiopathy due to portal cavernoma, there is no current standardized treatment approach. We report the case of a predominantly intrahepatic portal cavernoma occurring in a patient with chronic idiopathic portal vein thrombosis, which led to severe cholangiopathy that mimicked primary sclerosing cholangitis and cholangiocarcinoma, was unresponsive to endoscopic stent placement, and finally required liver transplantation. Copyright 2007 AASLD.

Entities:  

Mesh:

Year:  2007        PMID: 17763385     DOI: 10.1002/lt.21243

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  11 in total

1.  Obstructive jaundice caused by a portal cavernoma.

Authors:  Masato Takamatsu; Masayuki Furutake; Takeshi Hisa; Mizuho Ueda
Journal:  Jpn J Radiol       Date:  2010-12-30       Impact factor: 2.374

Review 2.  Portal vein thrombosis.

Authors:  Yogesh K Chawla; Vijay Bodh
Journal:  J Clin Exp Hepatol       Date:  2015-01-06

Review 3.  Surgical management of portal cavernoma cholangiopathy.

Authors:  Vibha Varma; Arunanshu Behera; Leileshwar Kaman; Somnath Chattopadhyay; Samiran Nundy
Journal:  J Clin Exp Hepatol       Date:  2013-09-17

4.  Portal biliary ductopathy caused by cavernous transformation of the portal vein.

Authors:  Jeffrey Chu-Nan Chong; Ray Boyapati; Ferry Rusli
Journal:  BMJ Case Rep       Date:  2013-01-31

Review 5.  Portal cavernoma cholangiopathy: consensus statement of a working party of the Indian national association for study of the liver.

Authors:  Radha K Dhiman; Vivek A Saraswat; Dominique C Valla; Yogesh Chawla; Arunanshu Behera; Vibha Varma; Swastik Agarwal; Ajay Duseja; Pankaj Puri; Naveen Kalra; Chittapuram S Rameshbabu; Vikram Bhatia; Malay Sharma; Manoj Kumar; Subhash Gupta; Sunil Taneja; Leileshwar Kaman; Showkat A Zargar; Samiran Nundy; Shivaram P Singh; Subrat K Acharya; Jang B Dilawari
Journal:  J Clin Exp Hepatol       Date:  2014-02-25

Review 6.  Liver transplantation for portal cavernoma cholangiopathy.

Authors:  Subash Gupta; Sunil Taneja
Journal:  J Clin Exp Hepatol       Date:  2014-01-17

7.  Long-Term Outcomes of Endoscopic Management of Patients with Symptomatic Portal Cavernoma Cholangiopathy with No Shuntable Veins for Surgery or Failed Surgery.

Authors:  Suprabhat Giri; Aditya Kale; Ankita Singh; Akash Shukla
Journal:  J Clin Exp Hepatol       Date:  2022-04-10

8.  Safety of supramesocolic surgery in patients with portal cavernoma without portal vein decompression. Large single centre experience.

Authors:  Safi Dokmak; Béatrice Aussilhou; Alain Sauvanet; Philippe Lévy; Aurélie Plessier; Fadhel S Ftériche; Olivier Farges; Valérie Vilgrain; Dominique C Valla; Jacques Belghiti
Journal:  HPB (Oxford)       Date:  2016-06-16       Impact factor: 3.647

Review 9.  Therapeutic approaches for portal biliopathy: A systematic review.

Authors:  Irene Franceschet; Alberto Zanetto; Alberto Ferrarese; Patrizia Burra; Marco Senzolo
Journal:  World J Gastroenterol       Date:  2016-12-07       Impact factor: 5.742

10.  The collateral caval shunt as an alternative to classical shunt procedures in patients with recurrent duodenal varices and extrahepatic portal vein thrombosis.

Authors:  Hans Michael Hau; Peter Fellmer; Markus B Schoenberg; Moritz Schmelzle; Mehmet Haluk Morgul; Felix Krenzien; Georg Wiltberger; Albrecht Hoffmeister; Sven Jonas
Journal:  Eur J Med Res       Date:  2014-06-25       Impact factor: 2.175

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.